Genten Therapeutics
San Francisco
About Genten Therapeutics
Genten Therapeutics develops a monotherapy through an antigen specific induction of immune tolerance for gluten. The company was incorporated in 2016 and is based in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $12.0M
- Last round: Series Unknown (Oct 2016)
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/genten-therapeutics-95078 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.